LA JOLLA PHARMACEUTICAL CO·4

Jan 14, 9:00 PM ET

Rosen Robert 4

4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 14, 2022

Insider Transaction Report

Form 4
Period: 2022-01-12
Rosen Robert
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-12+30,00030,000 total
    Exercise: $4.81Exp: 2032-01-12Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The stock options vest and become exercisable on January 12, 2023 subject to the Reporting Person's continued service to the Issuer through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION